Dr. Kelly received his PhD in immunology from University of Cambridge (UK) and MD from University of Alabama. He completed in residency training in CP and fellowship in BB/TM from Harvard Medical School. Dr. Kelley also held a Masters in Healthcare Management from Johns Hopkins and had his Postdoc training in genomics and stem cell biology. Dr. Kelley held faculty position at MD Anderson Cancer Center, served as Director at Terumo Blood and Cell Technologies and is currently the CMO at OneOme.